glp 1 agonist binge eating disorder GLP-1 receptor agonists: A novel pharmacotherapy for (Binge eating and bulimia nervosa)? A systematic review Nutritional priorities to support GLP-1

Metabolic Syndrome and Retatrutide : Metabolic syndrome is a cluster of conditions, including high blood pressure, high blood sugar, abnormal cholesterol levels, and excess abdominal fat, that significantly increase the risk of developing cardiovascular disease and type 2 diabetes

Kessing, L

Compound-Specific Oncologic Effects As highlighted in this meta-analysis, no conclusive association between the use of GLP-1 RAs and an increase in gastrointestinal cancers has been established

Zatorski H, Saaga M, Fichna J

Compared to control, significant reductions in intracranial pressure were seen acutely at 2.5 h and 24 h, but also at 12 weeks [101]